(IN BRIEF) Novo Nordisk’s SOUL trial has shown that oral semaglutide reduces the risk of major adverse cardiovascular events (MACE) by 14% in adults with type 2 diabetes and established cardiovascular disease or chronic kidney disease. The trial involved 9,650 … Read the full press release
(IN BRIEF) Novo Nordisk’s Alhemo® (concizumab) has been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). If approved, Alhemo® will become the first once-daily subcutaneous prophylactic treatment for people aged 12 … Read the full press release
Posted in Business, Denmark, Environment, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Alhemo®, Haemophilia A and B with Inhibitors, Novo Nordisk, Once-Daily Subcutaneous Treatment, safety, Stephanie Seremetis, sustainbility
(IN BRIEF) Novo Nordisk has launched the Childhood Obesity Prevention Initiative, aimed at combating rising obesity rates among children in underserved urban communities across six cities worldwide. Backed by an investment of over 250 million Danish kroner and a coalition … Read the full press release
Posted in Business, Denmark, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Brazil, CANADA, France, Global Childhood Obesity Initiative, Healthier Urban Communities, Japan, Katrine DiBona, Novo Nordisk, partnership, South Africa, Spain, sustainability, wellbeing
(IN BRIEF) EQT Life Sciences proudly announces Novo Nordisk’s acquisition of Cardior Pharmaceuticals, valuing the biopharmaceutical company at up to EUR 1.025 billion. Based in Hannover, Germany, Cardior specializes in RNA-based therapeutics for cardiovascular diseases, focusing initially on heart failure. … Read the full press release
Posted in Business, Denmark, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged acquisition, Cardior Pharmaceuticals, Christoph Broja, Claudia Ulbrich, Denmark, EQT, EQT Life Sciences, Germany, Heart Diseases, Novo Nordisk, partnership, Professor Thomas Thum, RNA Therapies, sustainability
(IN BRIEF) The Conference Forum announced the launch of the 8th annual Patients as Partners® Europe meeting, scheduled for May 14-15, 2024, at Plaisterers’ Hall in London, England. This event brings together pharma R&D and patient advocacy to discuss patient … Read the full press release
Posted in Healthcare, Marketing, Pharma & Biotech, United Kingdom
Tagged 8th annual Patients as Partners® Europe, AbbVie, Anders Lassen, Andrew Garvey, Annie Gilbert, Astellas, AstraZeneca, Biotech, Boehringer Ingelheim, clinical operations, clinical research, clinical trials, Conference, David James, decentralized clinical trials, Derek Stewart, diversifying clinical trials, diversity, drug development, England, GSK, Health Equity, inclusivity, inclusivity in clinical research, Ipsen, LGBTQ+ oncology, Lisa Kerr, London, Lundbeck, Novartis, Novo Nordisk, Oleksandr Gorbenko, Parexel, Patient Advocacy, patient engagment, patient experience mapping, Patrick Gallogly, Pfizer, pharma, Plaisterers’ Hall, Prostate Cancer Research, Rosamund Round, Sanofi, Sarah Zenner Dolan, Stephen Head, The Conference Forum, Valerie Bowling, Victoria DiBiaso, , Alfred Samuel
(IN BRIEF) Novo Nordisk is conducting a Capital Markets Day (CMD) to provide updates on its Strategic Aspirations 2025. The event will focus on various aspects, including corporate strategy, sustainability, research and development pipeline, and financial performance. Highlights include discussions … Read the full press release
Posted in Business, Denmark, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology
Tagged Capital Markets Day, Novo Nordisk, Strategic Aspirations 2025
(IN BRIEF) Novo Nordisk has announced promising headline results from the kidney outcomes trial FLOW, which compared injectable semaglutide 1.0 mg with placebo as an adjunct to standard care for people with type 2 diabetes and chronic kidney disease (CKD). … Read the full press release
Posted in Business, Denmark, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Flow, Kidney, Martin Holst Lange, Novo Nordisk, Ozempic, Semaglutide
(IN BRIEF) Novo Nordisk A/S has announced the date for its Annual General Meeting, scheduled for Thursday, March 21, 2024, at 14:00 CET. The meeting will be held partially electronically, allowing shareholders to participate either in person at Bella Center … Read the full press release
Posted in Business, Denmark, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology
Tagged Andreas Fibig, appointments, Board Re-election, Christina Law, Helge Lund, Henrik Poulsen, Kasim Kutay, Laurence Debroux, leadership, Martin Mackay, Novo Nordisk, Sylvie Grégoire
(IN BRIEF) Almirall S.A., a leading pharmaceutical company specializing in medical dermatology, has finalized an exclusive license agreement with Novo Nordisk for the development and commercialization of NN-8828, an IL-21 blocking monoclonal antibody. This innovative treatment holds potential for various … Read the full press release
Posted in Business, Denmark, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Spain, Technology
Tagged Almirall, Denmark, Dermatology, Dr. Karl Ziegelbauer, IL-21, NN-8828, Novo Nordisk, partnership, sustainability
(IN BRIEF) Novo Nordisk has announced separate research collaborations with Omega Therapeutics and Cellarity Inc. to explore innovative treatment approaches for obesity and MASH (Metabolic Associated Fatty Liver Disease). The collaboration with Omega aims to develop an epigenomic controller to … Read the full press release
Posted in Business, Denmark, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Cellarity Inc., Fabrice Chouraqui, innovative, Mahesh Karande, Marcus Schindler, MASH (Metabolic Associated Fatty Liver Disease), Novo Nordisk, Obesity, Omega Therapeutics, partnership, Paul Biondi, sustainability, treatments, USA
(IN BRIEF) Novo Nordisk has unveiled plans to invest more than 42 billion Danish kroner starting in 2023 to expand its existing manufacturing facilities in Kalundborg, Denmark. This significant investment coincides with the company’s 100th anniversary and underscores Novo Nordisk’s … Read the full press release
(IN BRIEF) DHL Global Forwarding is experiencing a rising demand for sustainable transport solutions using fuels like Sustainable Aviation Fuels. More shippers are requesting emissions transparency and exploring sustainable options, even with extra costs. DHL’s GoGreen Plus service, which uses … Read the full press release
Posted in Aviation & Aerospace, Business, Energy, Gas & Oil, Environment, Germany, Industrial, Management, News, Pharma & Biotech, Transportation & Logistics
Tagged Decarbonize Air Freight, DHL, Dorethe Nielsen, GoGreen Plus service, Novo Nordisk, partnership, sustainability, Sustainable Aviation Fuels, sustainable transport solutions, Thomas George
(IN BRIEF) Novo Nordisk, a global healthcare company, has reported the headline findings from the SELECT cardiovascular outcomes trial. This double-blinded study assessed the impact of subcutaneous once-weekly semaglutide 2.4 mg in comparison to placebo as an adjunct to standard … Read the full press release
Posted in Business, Denmark, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged Cardiovascular risk, Martin Holst Lange, Novo Nordisk, Obese Adults, overweight, SELECT Trial, Semaglutide 2.4 mg, Wegovy, wellness
(IN BRIEF) Novo Nordisk A/S is in exclusive negotiations to acquire a controlling stake in BIOCORP Production SA, a French company specializing in medical device design and manufacturing. The acquisition would be followed by a mandatory tender offer for all … Read the full press release
(IN KÜRZE) Die LEGO Group und Novo Nordisk haben sich mit European Energy zusammengetan, um E-Methanol, eine kohlenstoffärmere Alternative zu herkömmlichem Kunststoff, für einen Teil ihrer Materialproduktion zu verwenden. European Energy wird E-Methanol aus erneuerbarer Energie und biogenem CO2 produzieren, … Read the full press release
(IN BRIEF) The LEGO Group and Novo Nordisk have partnered with European Energy to use e-methanol, a lower-carbon alternative to conventional plastic, for some of their material production. European Energy will produce e-methanol from renewable energy and biogenic CO2, and … Read the full press release
(ACTUALITÉ EN BREF) Novo Nordisk a annoncé une collaboration avec Aspect Biosystems pour développer des thérapies tissulaires bio-imprimées pour le traitement du diabète et de l’obésité. La collaboration tirera parti de la technologie de bioimpression d’Aspect et de l’expertise de … Read the full press release
(IN BRIEF) Novo Nordisk has announced a collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics for diabetes and obesity treatment. The collaboration will leverage Aspect’s bioprinting technology and Novo Nordisk’s expertise in stem cell differentiation and cell therapy development … Read the full press release
(ACTUALITÉ EN BREF) Novo Nordisk a annoncé des changements dans son équipe de direction. Monique Carter, l’actuelle vice-présidente exécutive de Global People & Organisation, quitte l’entreprise pour poursuivre une opportunité externe et sera remplacé par Tania Sabroe, qui a été … Read the full press release
Posted in Business, Denmark, Management, News, Pharma & Biotech
Tagged biotechnologie, Dave Moore, direction générale, leadership, Monique Carter, nominations, Novo Nordisk, pharma, pharmaceutique, Tania Sabroe
(IN BRIEF) Novo Nordisk has announced changes to its executive management team. Monique Carter, the current EVP of Global People & Organisation, is leaving the company to pursue an external opportunity and will be succeeded by Tania Sabroe, who has … Read the full press release
Posted in Business, Denmark, Management, News, Pharma & Biotech
Tagged appointments, Biotech, Dave Moore, executive management, leadership, Monique Carter, Novo Nordisk, pharma, Pharmaceutical, Tania Sabroe
12 million litres of SAF (sustainable aviation fuel) to minimise environmental impact of Novo Nordisk air freight globally Sustainable fuel offering to support customers’ pledge for carbon-neutral shipping Advocating for more sustainable fuel production and use (PRESS RELEASE) SCHINDELLEGI, 20-Oct-2022 … Read the full press release
Posted in Business, Denmark, Energy, Gas & Oil, Environment, Healthcare, News, Switzerland, Transportation & Logistics
Tagged air freight, air freight shipments, air logistics, carbon reduction targets, Diabetes, Dorethe Nielsen, Kuehne+Nagel, Novo Nordisk, SAF, shipping, sustainable aviation fuel, Yngve Ruud
12 millones de litros de SAF (combustible de aviación sostenible) para minimizar el impacto ambiental de la carga aérea de Novo Nordisk a nivel mundial Oferta de combustible sostenible para respaldar el compromiso de los clientes de envíos sin emisiones … Read the full press release
Posted in Business, Denmark, Energy, Gas & Oil, Environment, Healthcare, Switzerland, Transportation & Logistics
Tagged carga aérea, combustible de aviación sostenible, Diabetes, Dorethe Nielsen, envíos de carga aérea, Kuehne+Nagel, logística aérea, Novo Nordisk, objetivos de reducción de carbono, SAF, transporte marítimo, Yngve Ruud
(PRESS RELEASE) BAAR, 18-Jul-2022 — /EuropaWire/ — Glencore (LON: GLEN), an Anglo-Swiss multinational commodity trading and mining company, has announced that Liz Hewitt has been appointed as an Independent Non-Executive Director at the company with effect as of 18 July … Read the full press release
Posted in Business, Industrial, Management, Metals and Minerals, News, Switzerland
Tagged 3i Group plc, appointment, Arthur Andersen & Co., Citicorp Venture Capital Ltd, Gartmore Investment Management Limited, Glencore plc, Kalidas Madhavpeddi, Liz Hewitt, Melrose Industries PLC, National Grid plc, Novo Nordisk, Savills plc, Smith& Nephew plc., Synergy Health plc
(COMMUNIQUÉ DE PRESSE) BAAR, 18-Jul-2022 — /EuropaWire/ — Glencore (LON : GLEN), une multinationale anglo-suisse spécialisée dans le commerce et l’exploitation de matières premières société, a annoncé que Liz Hewitt a été nommée administratrice indépendante non exécutive de la société avec … Read the full press release
Posted in Business, Industrial, Management, Metals and Minerals, Switzerland
Tagged 3i Group plc, appointment, Arthur Andersen & Co., Citicorp Venture Capital Ltd, Gartmore Investment Management Limited, Glencore plc, Kalidas Madhavpeddi, Liz Hewitt, Melrose Industries PLC, National Grid plc, Novo Nordisk, Savills plc, Smith & Nephew plc, Synergy Health plc
(PRESS RELEASE) STOCKHOLM, 1-Feb-2022 — /EuropaWire/ — Skandinaviska Enskilda Banken AB (STO: SEB-A) (SEB), a Swedish financial group leader on the Nordic market, has announced that its SEB Nordic Equity fund has become the Nordic Fund of the Year according … Read the full press release
Posted in Awards, Banks, Financial, Investment, Management, Sweden
Tagged Award, equities, Fondmarknaden.se, fund, Fund of the Year, investor, Nordic Fund of the Year, Novo Nordisk, Sandvik, SEB, SEB Nordic Equity fund, Stocks, Sverigefond Småbolag Chans/Risk, Swedish Fund of the Year, Tommi Saukkoriipi, Volvo
(PRESSEMITTEILUNG) STOCKHOLM, 1-Feb-2022 — /EuropaWire/ — Skandinaviska Enskilda Banken AB (STO: SEB-A) (SEB), ein schwedisches Finanzunternehmen Gruppenführer auf dem nordischen Markt, hat bekannt gegeben, dass sein SEB Nordic Equity-Fonds laut Fondmarknaden.se, Schwedens größtem Handelsplatz für Fonds, zum Nordic Fund of … Read the full press release
Posted in Awards, Banks, Financial, Investment, Management, Sweden
Tagged Aktien, Auszeichnung, Fonds, Fondsmarknaden.se, Fund of the Year, investor, Nordic Fund of the Year, Novo Nordisk, Sandvik, SEB, SEB Nordic Equity fund, Sverigefond Småbolag Chans/Risk, Swedish Fund of the Year, Tommi Saukkoriipi, Volvo
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
